Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 1.95
  • 52 Week Low: 0.59
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 1,890
  • Market Cap: £3.21m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
57.65% below the market average57.65% below the market average57.65% below the market average57.65% below the market average57.65% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
34.69% above the market average34.69% above the market average34.69% above the market average34.69% above the market average34.69% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Price Book Ratio
20.92% below the market average20.92% below the market average20.92% below the market average20.92% below the market average20.92% below the market average
38.10% above the sector average38.10% above the sector average38.10% above the sector average38.10% above the sector average38.10% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
72.67% above the market average72.67% above the market average72.67% above the market average72.67% above the market average72.67% above the market average
48.00% above the sector average48.00% above the sector average48.00% above the sector average48.00% above the sector average48.00% above the sector average
Price Chg 3m
48.67% below the market average48.67% below the market average48.67% below the market average48.67% below the market average48.67% below the market average
36% below the sector average36% below the sector average36% below the sector average36% below the sector average36% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
69.66% above the market average69.66% above the market average69.66% above the market average69.66% above the market average69.66% above the market average
69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average69.57% above the sector average
Momentum 20
31.86% above the market average31.86% above the market average31.86% above the market average31.86% above the market average31.86% above the market average
39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average39.13% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
89.83% below the market average89.83% below the market average89.83% below the market average89.83% below the market average89.83% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
52.83% below the market average52.83% below the market average52.83% below the market average52.83% below the market average52.83% below the market average
6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average6.12% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
87.45% below the market average87.45% below the market average87.45% below the market average87.45% below the market average87.45% below the market average
72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average72.22% below the sector average
Operating Profit Loss
65.12% below the market average65.12% below the market average65.12% below the market average65.12% below the market average65.12% below the market average
2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average2.04% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
66.06% below the market average66.06% below the market average66.06% below the market average66.06% below the market average66.06% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average
Cash
43% below the market average43% below the market average43% below the market average43% below the market average43% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
28.46% below the market average28.46% below the market average28.46% below the market average28.46% below the market average28.46% below the market average
46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average46.15% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 1.95
52 Week Low 0.59
Volume 1,890
Shares Issued 427.35m
Market Cap £3.21m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
31.57% below the market average31.57% below the market average31.57% below the market average31.57% below the market average31.57% below the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average
Price Trend
74.81% below the market average74.81% below the market average74.81% below the market average74.81% below the market average74.81% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average
Income Not Available
Growth
17.16% below the market average17.16% below the market average17.16% below the market average17.16% below the market average17.16% below the market average
35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average35.29% below the sector average

Theracryf Dividends

No dividends found

Trades for 09-Oct-2024

Time Volume / Share Price
13:02 1,890 @ 0.70p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page